compounded tirzepatide fsa eligible Ivím Health This dual Compound Tirzepatide
Description
The initial dose is gradually increased to achieve better glycemic control: Starting dose : 0.25 mg once weekly for the first 4 weeks (not effective for glycemic control)
Allergic reactions, such as a rash, swelling of the face, lips, tongue, or throat, and difficulty breathing, are rare but serious
It is one of the most studied GLP-1 therapies, serving as a benchmark for newer agents
Bacteriostatic Water, or 'bac water,' is sterile water that contains 0.9% benzyl alcohol
